ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s share price traded down 3.9% during trading on Monday . The company traded as low as $0.52 and last traded at $0.58. 3,965,537 shares changed hands during mid-day trading, an increase of 19,409% from the average session volume of 20,327 shares. The stock had previously closed at $0.60.
ImmunoPrecise Antibodies Stock Down 3.9 %
The stock’s fifty day simple moving average is $0.44 and its 200 day simple moving average is $0.60.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Sizing Up a New Opportunity for NVIDIA Investors
- How to trade using analyst ratings
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Stock Market Upgrades: What Are They?
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
